Skip to main content

Table 1 Relation between serum level of IL-17 and sociodemographic characteristics of the studied subjects (n = 100)

From: Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity

 

IL-17 (pg/mL)

Test of significance

Age/years

  

18–30

57.5 (14–210) (32.5–76.5)

KW = 6.18

30–40

55 (15–160) (32.0–73.0)

P = 0.103

40–50

64.5 (15–502) (45–82)

 

50–60

78 (14–260) (63–86)

 

Gender

  

Male

62 (14–260) (39.5–78.5)

Z = 0.01

Female

60.5 (14–502) (44.75–81.25)

P = 0.992

Residence

  

Urban

61.5 (14–502) (36.75–78.5)

Z = 0.434

Rural

62 (15–260) (41.25–79.5)

P = 0.664

Special habits

  

Smoking

62 (16–260) (40.25–79)

Z = 0.108

No

61.5 (14–502) (39.5–80)

P = 0.914

Surgical history

  

Yes

68 (14–210) (60.5–92.75)

Z = 1.72

No

59.5 (14–502) (35-77.25)

P = 0.085

Diabetes mellitus

  

Yes

78 (14–95) (18–90.5)

Z = 0.316

No

62 (14–502) (42–78)

P = 0.752

Hypertension

  

Yes

75 (62–86) (64.5–84)

Z = 1.38

No

60.5 (14–502) (36.5–79.5)

P = 0.167

  1. IL-17 described as median (min - max) (interquartile range), KW: Kruskal Wallis, Z:Mann Whitney U test*statistically significant